[Federal Register: October 8, 2009 (Volume 74, Number 194)]
[Notices]
[Page 51903-51904]
[DOCID:fr08oc09-97]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-60769; File No. SR-ISE-2009-68]

Self-Regulatory Organizations; International Securities Exchange,
LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule
Change Relating To Amending the Direct Edge ECN Fee Schedule

October 2, 2009.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(the ``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given
that on September 30, 2009, the International Securities Exchange, LLC
(the ``Exchange'' or the ``ISE'') filed with the Securities and
Exchange Commission (``Commission'') the proposed rule change as
described in Items I, II, and III below, which items have been prepared
by the self-regulatory organization. The Commission is publishing this
notice to solicit comments on the proposed rule change from interested
persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to amend Direct Edge ECN's (``DECN'') fee
schedule for ISE Members \3\ to (i) adopt new fees and rebates and
associated flags; (ii) amend the criteria for meeting the Ultra Tier;
(iii) to amend the descriptions of certain flags in the schedule; and
(iv) to amend its fee schedule to reflect pass through charges of other
market centers. All of the changes described herein are applicable to
ISE Members.
---------------------------------------------------------------------------

    \3\ References to ISE Members in this filing refer to DECN
Subscribers who are ISE Members.
---------------------------------------------------------------------------

    All of the changes described herein are applicable to ISE Members.
The text of the proposed rule change is available on the Exchange's
Internet Web site at http://www.ise.com.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of these statements may be examined at
the places specified in Item IV below. The self-regulatory organization
has prepared summaries, set forth in sections A, B and C below, of the
most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    DECN, a facility of ISE, operates two trading platforms, EDGX and
EDGA. On July 1, 2009,\4\ the Exchange adopted a new Ultra Tier Rebate,
as defined below, whereby ISE Members are provided a $0.0032 rebate per
share for securities priced at or above $1.00 when ISE Members add
liquidity on EDGX if the attributed MPID satisfies one of the following
criteria on a daily basis, measured monthly: (i) Adding 100,000,000
shares or more on EDGX; or (ii) adding 50,000,000 shares or more of
liquidity to EDGX, so long as added liquidity on EDGX is at least
20,000,000 shares greater than the previous calendar month. The rebate
described above is referred to as an ``Ultra Tier Rebate'' on the DECN
fee schedule.
---------------------------------------------------------------------------

    \4\ See Securities and Exchange Act Release No. 60232 (July 2,
2009), 74 FR 33309 (July 10, 2009) (SR-ISE-2009-43).
---------------------------------------------------------------------------

    The Exchange is now proposing to amend the criteria for meeting
this tier by allowing ISE Members to receive a $0.0032 rebate per share
for securities priced at or above $1.00 when ISE Members add liquidity
on EDGX if the attributed MPID posts 1% of the Total Consolidated
Volume (``TCV'') in average daily volume (``ADV''). TCV is defined as
volume reported by all exchanges and trade reporting facilities to the
consolidated transaction reporting plans for Tape A, B, and C
securities. At the same time, the Exchange is proposing to delete the
Full Sweep Tier, which provided a $0.0035 rebate per share for
liquidity added on EDGX if the attributed MPID added 50,000,000 shares
or more on a daily basis, measured monthly, by using the ROUT routing
strategy.
    The Ultra Tier rebate ($0.0032 per share), which is a higher rebate
than the Super Tier ($0.0030 per share), is also more difficult to
reach than the Super Tier rebate, as a higher volume threshold is
required based on recent TCV figures. For example, 1% of the average
TCV for July 2009 (8.8 billion) was approximately 88 million shares.
This threshold far exceeds the criteria to meet the Super Tier rebate.
In addition, the higher rebate also results in part from lower
administrative costs associated with higher volume.
    The Exchange also proposes to adopt additional fees and rebates.
First, the Exchange proposes to add new fee categories for the INET
order type. When a member routes to Nasdaq using the INET order type
and removes liquidity on Tapes A or C, the member would incur a fee of
$0.0030 on either EDGA or EDGX. Such situation would yield new Flag
``L''. The INET order type sweeps the EDGA or EDGX book, and routes the
remainder to Nasdaq. If the order is marketable, it will remove
liquidity from the EDGA or EDGX book, as applicable, first. If the
order is non-marketable, the order will post on Nasdaq. With regards to
a Member's use of the INET order type for Tapes A or C securities,
Members routing an ADV: (i) Less than 5,000,000 shares will be charged
$0.0030 per share, as described in the schedule; (ii) equal to or
greater than 5,000,000 shares but less than 20,000,000 shares will be
charged $0.0027 per share; (iii) equal to or greater than 20,000,000
shares but less than 30,000,001 shares will be charged $0.0026 per
share; and (iv) equal to or greater than 30,000,001 shares will be
charged $0.0025 per share. The rates, in all cases, are calculated for
shares removed from Nasdaq. The Exchange believes that these tier-based
rates will incent Members to sweep the EDGA or EDGX book first and then
offer a discounted rate to Nasdaq's rates if the remainder of the order
is routed to Nasdaq. These discounted rates arise in part from reduced
administrative costs associated with certain volume levels.
    Similarly, the Exchange also proposes to add an additional fee
category for the INET order type when a member routes to Nasdaq using
the INET order type and removes liquidity on Tape B. Such situation
would yield new flag ``2''. With regards to a Member's use of the INET
order type for Tape B securities, Members routing an ADV: (i) Less than
20,000,000 shares will be charged $0.0030 per share, as described in
the schedule; (ii) equal to or greater than 20,000,000 but less than
30,000,001 shares will be charged $0.0029 per share; and (iii) equal to
or greater than 30,000,001 shares will be charged $0.0028 per share.
    Furthermore, the Exchange proposes to adopt a new rebate. Members
will receive a rebate of $0.0032 per share for all liquidity posted on
EDGX if they add or route at least 10,000,000 shares of ADV to EDGX
prior to 9:30 AM EST or after 4:00 PM EST (includes all flags except N
and W) and add a minimum of 75,000,000 shares of ADV on EDGX in total,
including during both market hours and pre- and post-trading hours.
This rebate is designed to reward members who add or route significant
order flow to EDGX both during market

hours and pre and post-trading hours. It is also designed to increase
the liquidity of the pre and post markets.
    The Exchange proposes to amend the descriptions of the ``N'' and
``W'' flags to display which Tape liquidity is removed from. For the
``N'' flag, the Exchange proposes to amend the description to state
that liquidity is removed from Tapes B & C. For the ``W'' flag, the
Exchange proposes to amend the description to state that liquidity is
removed from Tape A.
    Finally, the Exchange proposes to pass through to Exchange members
the actual transaction fees assessed by away markets. Specifically, the
Exchange is proposing to amend its fees schedule to reflect Nasdaq's
reduction in rebate from 0.0006 to 0.0001 for removing liquidity from
Nasdaq OMX BX.
    The fee changes discussed in this filing will become operative on
October 1, 2009.
2. Statutory Basis
    The Exchange believes that the proposed rule change is consistent
with the objectives of Section 6 of the Act,\5\ in general, and
furthers the objectives of Section 6(b)(4),\6\ in particular, in that
it is designed to provide for the equitable allocation of reasonable
dues, fees and other charges among its members and other persons using
its facilities. In particular, adopting an additional rebate and
providing tier-based rates if Members use the INET order type provide
pricing incentives to market participants who route orders to DECN,
allowing DECN to remain competitive. ISE notes that DECN operates in a
highly competitive market in which market participants can readily
direct order flow to competing venues if they deem fee levels at a
particular venue to be excessive. The proposed rule change reflects a
competitive pricing structure designed to incent market participants to
direct their order flow to DECN. ISE believes the fees and credits
remain competitive with those charged by other venues and therefore
continue to be reasonable and equitably allocated to those members that
opt to direct orders to DECN rather than competing venues. The rebates
also provide incentives to members who add or route significant order
flow to EDGX both during market hours and pre and post-trading hours
and are designed to increase the liquidity of the pre and post markets.
Finally, the Exchange believes that the proposed rates are equitable in
that they apply uniformly to all Members and provide higher rebates for
higher volume thresholds, resulting from lower administrative costs.
---------------------------------------------------------------------------

    \5\ 15 U.S.C. 78f.
    \6\ 15 U.S.C. 78f(b)(4).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The proposed rule change does not impose any burden on competition
that is not necessary or appropriate in furtherance of the purposes of
the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants or Others

    The Exchange has not solicited, and does not intend to solicit,
comments on this proposed rule change. The Exchange has not received
any unsolicited written comments from members or other interested
parties.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The foregoing rule change has become effective pursuant to Section
19(b)(3) of the Act \7\ and Rule 19b-4(f)(2) \8\ thereunder. At any
time within 60 days of the filing of such proposed rule change, the
Commission may summarily abrogate such rule change if it appears to the
Commission that such action is necessary or appropriate in the public
interest, for the protection of investors, or otherwise in furtherance
of the purposes of the Act.
---------------------------------------------------------------------------

    \7\ 15 U.S.C. 78s(b)(3)(A).
    \8\ 17 CFR 19b-4(f)(2).
---------------------------------------------------------------------------

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://
www.sec.gov/rules/sro.shtml); or
     Send an e-mail to<EMAIL_ADDRESS>Please include
File Number SR-ISE-2009-68 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-ISE-2009-68. This file
number should be included on the subject line if e-mail is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/
sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for inspection and
copying in the Commission's Public Reference Room, 100 F Street, NE.,
Washington, DC 20549, on official business days between the hours of 10
a.m. and 3 p.m. Copies of the filing also will be available for
inspection and copying at the principal office of the ISE. All comments
received will be posted without change; the Commission does not edit
personal identifying information from submissions. You should submit
only information that you wish to make available publicly.
    All submissions should refer to File Number SR-ISE-2009-68 and
should be submitted on or before October 29, 2009.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\9\
---------------------------------------------------------------------------

    \9\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Florence E. Harmon,
Deputy Secretary.
[FR Doc. E9-24263 Filed 10-7-09; 8:45 am]

BILLING CODE 8011-01-P


[Federal Register Volume 81, Number 22 (Wednesday, February 3, 2016)]
[Notices]
[Pages 5763-5764]
[FR Doc No: 2016-01883]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0194]

Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Biosimilar User Fee Cover Sheet;
Form FDA 3792

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Biosimilar User Fee Cover Sheet;
Form FDA 3792'' has been approved by the Office of Management and
Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: On June 23, 2015, the Agency submitted a
proposed collection of information entitled ``Biosimilar User Fee Cover
Sheet; Form FDA 3792'' to OMB for review and clearance under 44 U.S.C.
3507. An Agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays
a currently valid OMB control number. OMB has now approved the
information collection and has assigned OMB control number 0910-0718.
The approval expires on December 31, 2018. A copy of the supporting
statement for this

information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain.

    Dated: January 28, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-01883 Filed 2-2-16; 8:45 am]
 BILLING CODE 4164-01-P


Episode 6000 Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

100.00 10.00 1.00 0.10 0.01 10^ 4 100.0 10.0 1.0 0.1 10^ 4 100.0 10.0 1.0 0.1 10^ 4 100.00 10.00 1.00 0.10 0.01 Organics, Method 1625: T= 0Organics, 0 BENZO( GHI) PERYLENE, NG/ ULBENZO( UL 100.0 10.0 1.0 0.1 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 0.05 Organics, Method 1625: T= 0Organics, 0 BIPHENYL, NG/ ULBIPHENYL, UL 100.00 10.00 1.00 0.10 0.01 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 10^ 4 Organics, Method 1625: T= 0Organics, 0 BIS( 2 CHLOROISOPROPYL) ETHER, NG/ ULBIS( UL 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 10^ 4 Organics, Method 1625: T= 0Organics, 0 CARBAZOLE, NG/ ULCARBAZOLE, UL 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 0.05 100.00 10.00 1.00 0.10 0.01 0.50 5.00 50.00 10^ 4 100.00 10.00 Organics, Method 1625: T= 0Organics, 0 BIS( 2 CHLOROETHOXY) METHANE, NG/ ULBIS( UL 1.00 0.10 0.01 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 10^ 4 Organics, Method 1625: T= 0Organics, 0 BIS( 2 ETHYLHEXYL) PHTHALATE, NG/ ULBIS( UL 100.0 10.0 1.0 0.1 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 10^ 4 Organics, Method 1625: T= 0Organics, 0 CHRYSENE, NG/ ULCHRYSENE, UL 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.50 5.00 50.00 0.05 Organics, Method 1625: T= 0Organics, 0 BENZO( K) FLUORANTHENE, NG/ ULBENZO( UL Page 21 of 32 Organics, Method 1625: T= 0Organics, 0 BETA NAPHTHYLAMINE, NG/ ULBETA UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 BIS( 2 CHLOROETHYL) ETHER, NG/ ULBIS( UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 BUTYL BENZYL PHTHALATE, NG/ ULBUTYL UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 DI N BUTYL PHTHALATE, NG/ ULDI UL 0.50 5.00 50.00 Log 10 of Measured Concentration Mon Mar 18 16: 44: 28 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req004/ r004sd1. s Episode 6000 Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.05 0.50 5.00 50.00 Organics, Method 1625: T= 0Organics, 0 DI N OCTYL PHTHALATE, NG/ ULDI UL 100.0 10.0 1.0 0.1 Organics, Method 1625: T= 0Organics, 0 DIBENZOFURAN, NG/ ULDIBENZOFURAN, UL 0.05 0.50 5.00 50.00 100.00 10.00 1.00 0.10 0.01 Organics, Method 1625: T= 0Organics, 0 DIMETHYL PHTHALATE, NG/ ULDIMETHYL UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 100.00 10.00 1.00 0.10 0.01 Organics, Method 1625: T= 0Organics, 0 FLUORANTHENE, NG/ ULFLUORANTHENE, UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Mon Mar 18 16: 44: 43 2002 100.00 10.00 1.00 0.10 0.01 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 DI N PROPYLNITROSAMINE, NG/ ULDI UL 100.00 10.00 1.00 0.10 0.01 Organics, Method 1625: T= 0Organics, 0 DIBENZOTHIOPHENE, NG/ ULDIBENZOTHIOPHENE, UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 100.00 10.00 1.00 0.10 0.01 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 DIPHENYL ETHER, NG/ ULDIPHENYL UL 100.00 10.00 1.00 0.10 0.01 Organics, Method 1625: T= 0Organics, 0 FLUORENE, NG/ ULFLUORENE, UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Log 10 of Spike Concentration 100.0 10.0 1.0 0.1 0.05 100.0 10.0 1.0 0.1 10^ 4 100.00 10.00 1.00 0.10 0.01 10^ 4 100.00 10.00 1.00 0.10 0.01 Page 22 of 32 Organics, Method 1625: T= 0Organics, 0 DIBENZO( A, H) ANTHRACENE, NG/ ULDIBENZO( UL 0.50 5.00 50.00 Organics, Method 1625: T= 0Organics, 0 DIETHYL PHTHALATE, NG/ ULDIETHYL UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 DIPHENYLAMINE, NG/ ULDIPHENYLAMINE, UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 HEXACHLOROBENZENE, NG/ ULHEXACHLOROBENZENE, UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 c:/ pw/ ostmdl/ req004/ r004sd1. s Log 10 of Measured Concentration Episode 6000 Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

Organics, Method 1625: T= 0Organics, 0 HEXACHLOROBUTADIENE, NG/ ULHEXACHLOROBUTADIENE, UL 0.50 5.00 50.00 Organics, Method 1625: T= 0Organics, 0 INDENO( 1,2,3 CD) PYRENE, NG/ ULINDENO( UL 0.50 5.00 50.00 Organics, Method 1625: T= 0Organics, 0 N DOCOSANE, NG/ ULN UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 N HEXACOSANE, NG/ ULN UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 HEXACHLOROCYCLOPENTADIENE, NG/ ULHEXACHLOROCYCLOPENTADIENE, UL 0.50 5.00 50.00 Organics, Method 1625: T= 0Organics, 0 ISOPHORONE, NG/ ULISOPHORONE, UL 0.50 5.00 50.00 Organics, Method 1625: T= 0Organics, 0 N DODECANE, NG/ ULN UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 N HEXADECANE, NG/ ULN UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Page 23 of 32 Organics, Method 1625: T= 0Organics, 0 HEXACHLOROETHANE, NG/ ULHEXACHLOROETHANE, UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 N DECANE, NG/ ULN UL 0.50 5.00 50.00 Organics, Method 1625: T= 0Organics, 0 N EICOSANE, NG/ ULN UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 N NITROSODIMETHYLAMINE, NG/ ULN UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 c:/ pw/ ostmdl/ req004/ r004sd1. s 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.05 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.05 100.00 10.00 1.00 0.10 0.01 10^ 4 100.0 10.0 1.0 0.1 100.0 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.05 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.05 100.00 10.00 1.00 0.10 0.01 10^ 4 100.00 10.00 1.00 0.10 0.01 10.0 1.0 0.1 10^ 4 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.05 100.00 10.00 1.00 0.10 0.01 10^ 4 100.00 10.00 1.00 0.10 0.01 Log 10 of Measured Concentration Log 10 of Spike Concentration Mon Mar 18 16: 44: 57 2002 Episode 6000 Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

100.00 10.00 1.00 0.10 0.01 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 N NITROSODIPHENYLAMINE, NG/ ULN UL 50.0 10.0 5.0 1.0 0.5 Organics, Method 1625: T= 0Organics, 0 N TETRACOSANE, NG/ ULN UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 100.00 10.00 1.00 0.10 0.01 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 NAPHTHALENE, NG/ ULNAPHTHALENE, UL 100.0 10.0 1.0 0.1 Organics, Method 1625: T= 0Organics, 0 PENTACHLOROPHENOL, NG/ ULPENTACHLOROPHENOL, UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Mon Mar 18 16: 45: 11 2002 100.0 10.0 1.0 0.1 Organics, Method 1625: T= 0Organics, 0 N OCTACOSANE, NG/ ULN UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 100.00 10.00 1.00 0.10 0.01 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 N TETRADECANE, NG/ ULN UL 100.00 10.00 1.00 0.10 0.01 0.05 0.50 5.00 50.00 Organics, Method 1625: T= 0Organics, 0 NITROBENZENE, NG/ ULNITROBENZENE, UL 100.00 10.00 1.00 0.10 0.01 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 PHENANTHRENE, NG/ ULPHENANTHRENE, UL Log 10 of Spike Concentration 100.00 10.00 1.00 0.10 0.01 10^ 4 100.00 10.00 1.00 0.10 0.01 10^ 4 100.00 10.00 1.00 0.10 0.01 10^ 4 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 Page 24 of 32 Organics, Method 1625: T= 0Organics, 0 N OCTADECANE, NG/ ULN UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 N TRIACONTANE, NG/ ULN UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 P CYMENE, NG/ ULP UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 0Organics, 0 PHENOL, NG/ ULPHENOL, UL 0.05 0.50 5.00 50.00 c:/ pw/ ostmdl/ req004/ r004sd1. s Log 10 of Measured Concentration Episode 6000 Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

Organics, Method 1625: T= 0Organics, 0 PHENOL, 2 METHYL 4,6 DINITRO, NG/ ULPHENOL, UL 10.0 1.0 0.1 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 100.00 10.00 1.00 0.10 0.01 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 1000Organics, 1000 1,2,3 TRICHLOROBENZENE, NG/ UL1,2,3 UL 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.05 0.50 5.00 50.00 Organics, Method 1625: T= 1000Organics, 1000 1,2 DIPHENYLHYDRAZINE, NG/ UL1,2 UL 100.0 10.0 1.0 0.1 Organics, Method 1625: T= 1000Organics, 1000 2,3,6 TRICHLOROPHENOL, NG/ UL2,3,6 UL 0.05 0.50 5.00 50.00 Mon Mar 18 16: 45: 25 2002 100.0 100.00 Organics, Method 1625: T= 0Organics, 0 PYRENE, NG/ ULPYRENE, UL 10.00 1.00 0.10 0.01 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 100.00 10.00 1.00 0.10 0.01 Organics, Method 1625: T= 1000Organics, 1000 1,2,4 TRICHLOROBENZENE, NG/ UL1,2,4 UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.05 0.50 5.00 50.00 Organics, Method 1625: T= 1000Organics, 1000 1,3 DICHLOROBENZENE, NG/ UL1,3 UL 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.05 0.50 5.00 50.00 Organics, Method 1625: T= 1000Organics, 1000 2,4,5 TRICHLOROPHENOL, NG/ UL2,4,5 UL Log 10 of Spike Concentration 100.00 10.00 1.00 0.10 0.01 10^ 4 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.05 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 10^ 4 100.0 10.0 1.0 0.1 Page 25 of 32 Organics, Method 1625: T= 0Organics, 0 STYRENE, NG/ ULSTYRENE, UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 1000Organics, 1000 1,2 DICHLOROBENZENE, NG/ UL1,2 UL 0.50 5.00 50.00 Organics, Method 1625: T= 1000Organics, 1000 1,4 DICHLOROBENZENE, NG/ UL1,4 UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 1000Organics, 1000 2,4,6 TRICHLOROPHENOL, NG/ UL2,4,6 UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 c:/ pw/ ostmdl/ req004/ r004sd1. s Log 10 of Measured Concentration Episode 6000 Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

Log 10 of Measured Concentration 100.0 Organics, Method 1625: T= 1000Organics, 1000 2,4 DICHLOROPHENOL, NG/ UL2,4 UL 100.00 Organics, Method 1625: T= 1000Organics, 1000 2,4 DIMETHYLPHENOL, NG/ UL2,4 UL 100.0 50.0 50.00 10.00 10.0 10.0 5.00 5.0 1.00 1.0 1.0 0.50 0.5 0.10.10 0.1 0.05 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 0.05 0.50 5.00 50.00 0.05 0.50 5.00 50.00 Page 26 of 32 Organics, Method 1625: T= 1000Organics, 1000 2,4 DINITROPHENOL, NG/ UL2,4 UL 100.0 Organics, Method 1625: T= 1000Organics, 1000 2,4 DINITROTOLUENE, NG/ UL2,4 UL 100.0 Organics, Method 1625: T= 1000Organics, 1000 2,6 DINITROTOLUENE, NG/ UL2,6 UL 100.00 50.0 50.00 10.0 10.0 10.00 5.0 5.00 1.0 1.001.0 0.50 0.5 0.1 0.10 0.1 0.05 Organics, Method 1625: T= 1000Organics, 1000 2 CHLORONAPHTHALENE, NG/ UL2 UL 0.05 0.50 5.00 50.00 0.1 0.5 5.0 50.0 0.05 0.50 5.00 50.00 100.0 Organics, Method 1625: T= 1000Organics, 1000 2 CHLOROPHENOL, NG/ UL2 UL 100.00 Organics, Method 1625: T= 1000Organics, 1000 2 NITROPHENOL, NG/ UL2 UL 100.0 50.00 50.0 Organics, Method 1625: T= 1000Organics, 1000 2 PICOLINE, NG/ UL2 UL 10.0 10.00 10.0 5.00 5.0 1.0 1.00 0.50 1.0 0.5 0.1 0.10 0.05 0.05 0.50 5.00 50.00 0.05 0.50 5.00 50.00 0.5 1.0 5.0 10.0 50.0 100.0 Organics, Method 1625: T= 1000Organics, 1000 3,3' DICHLOROBENZIDINE, NG/ UL3,3' UL 100.00 Organics, Method 1625: T= 1000Organics, 1000 4 BROMOPHENYL PHENYL ETHER, NG/ UL4 UL 100.0 10.00 10.0 10.0 1.00 1.0 1.0 0.10 0.1 0.1 0.01 0.05 0.50 5.00 50.00 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 1000Organics, 1000 4 CHLORO 3 METHYLPHENOL, NG/ UL4 UL Mon Mar 18 16: 45: 39 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req004/ r004sd1. s Log 10 of Measured Concentration Episode 6000 Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

100.00 Organics, Method 1625: T= 1000Organics, 1000 4 CHLOROPHENYLPHENYL ETHER, NG/ UL4 UL 100.0 Organics, Method 1625: T= 1000Organics, 1000 4 NITROPHENOL, NG/ UL4 UL 100.00 50.00 50.0 10.00 10.00 10.0 5.00 1.00 5.0 1.00 0.10 0.50 1.0 0.01 0.5 0.10 0.05 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 1 5 10 50 100 0.05 0.50 5.00 50.00 Page 27 of 32 Organics, Method 1625: T= 1000Organics, 1000 ACENAPHTHENE, NG/ ULACENAPHTHENE, UL 100.0 Organics, Method 1625: T= 1000Organics, 1000 ACENAPHTHYLENE, NG/ ULACENAPHTHYLENE, UL 100.0 Organics, Method 1625: T= 1000Organics, 1000 ALPHA TERPINEOL, NG/ ULALPHA UL 100.00 50.00 10.0 10.0 10.00 5.00 1.0 1.0 1.00 0.50 0.1 0.1 0.10 0.05 Organics, Method 1625: T= 1000Organics, 1000 ANTHRACENE, NG/ ULANTHRACENE, UL 0.05 0.50 5.00 50.00 0.05 0.50 5.00 50.00 0.05 0.50 5.00 50.00 Organics, Method 1625: T= 1000Organics, 1000 BENZO( A) PYRENE, NG/ ULBENZO( UL 100.00 100.00 100.00 50.00 50.00 10.00 10.00 10.00 5.00 5.00 1.00 1.00 Organics, Method 1625: T= 1000Organics, 1000 BENZIDINE, NG/ ULBENZIDINE, UL 1.00 0.50 0.50 0.10 0.10 0.10 0.05 0.05 Organics, Method 1625: T= 1000Organics, 1000 BENZO( A) ANTHRACENE, NG/ ULBENZO( UL 0.01 0.05 0.50 5.00 50.00 0.05 0.50 5.00 50.00 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 100.0 Organics, Method 1625: T= 1000Organics, 1000 BENZO( B) FLUORANTHENE, NG/ ULBENZO( UL 100.0 Organics, Method 1625: T= 1000Organics, 1000 BENZO( GHI) PERYLENE, NG/ ULBENZO( UL 100.0 10.0 10.0 10.0 1.0 1.0 1.0 0.1 0.1 0.1 Organics, Method 1625: T= 1000Organics, 1000 BENZO( K) FLUORANTHENE, NG/ ULBENZO( UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 0.05 0.50 5.00 50.00 Mon Mar 18 16: 45: 52 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req004/ r004sd1. s BIS( 2 CHLOROETHOXY) METHANE, NG/ ULBIS( UL Episode 6000 Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

100.0 100.0 100.00 50.00 Organics, Method 1625: T= 1000Organics, 1000 BETA NAPHTHYLAMINE, NG/ ULBETA UL Organics, Method 1625: T= 1000Organics, 1000 BIPHENYL, NG/ ULBIPHENYL, UL Page 28 of 32 Organics, Method 1625: T= 1000Organics, 1000 0.50 5.00 50.00 Organics, Method 1625: T= 1000Organics, 1000 BIS( 2 ETHYLHEXYL) PHTHALATE, NG/ ULBIS( UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 1000Organics, 1000 CHRYSENE, NG/ ULCHRYSENE, UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 1000Organics, 1000 DI N PROPYLNITROSAMINE, NG/ ULDI UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 10.0 1.0 0.1 0.05 100.00 10.00 1.00 0.10 0.01 10^ 4 100.0 10.0 1.0 0.1 10^ 4 100.00 10.00 1.00 0.10 0.01 10.0 10.00 5.00 1.0 1.00 0.50 0.1 0.10 0.05 0.50 5.00 50.00 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 0.05 Organics, Method 1625: T= 1000Organics, 1000 BIS( 2 CHLOROETHYL) ETHER, NG/ ULBIS( UL 100.00 Organics, Method 1625: T= 1000Organics, 1000 BIS( 2 CHLOROISOPROPYL) ETHER, NG/ ULBIS( UL 100.0 50.00 10.00 10.0 5.00 1.0 1.00 0.50 0.1 0.10 0.05 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 0.1 0.5 5.0 50.0 10^ 4 Organics, Method 1625: T= 1000Organics, 1000 BUTYL BENZYL PHTHALATE, NG/ ULBUTYL UL 100.00 Organics, Method 1625: T= 1000Organics, 1000 CARBAZOLE, NG/ ULCARBAZOLE, UL 100.00 50.00 10.00 10.00 5.00 1.00 1.00 0.10 0.50 0.01 0.10 0.05 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 0.05 0.50 5.00 50.00 10^ 4 Organics, Method 1625: T= 1000Organics, 1000 DI N BUTYL PHTHALATE, NG/ ULDI UL 100.0 Organics, Method 1625: T= 1000Organics, 1000 DI N OCTYL PHTHALATE, NG/ ULDI UL 100.00 10.0 10.00 1.00 1.0 0.10 0.1 0.01 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 0.05 0.50 5.00 50.00 10^ 4 Log 10 of Measured Concentration Mon Mar 18 16: 46: 06 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req004/ r004sd1. s 0.050.505.0050.00 0.1 0.5 1.0 5.0 10.0 50.0 100.0Organics, Method 1625: T= 1000Organics, 1000 DIBENZO( A, H) ANTHRACENE, NG/ ULDIBENZO( UL Measurement Results vs Spike Concentrations ( Log 10 Scale) Episode 6000 DataPage 29 of 32 Log 10 of Measured Concentration Log 10 of Spike Concentrationc:/ pw/ ostmdl/ req004/ r004sd1. sMon Mar 18 16: 46: 20 2002 0.050.505.0050.00 0.05 0.10 0.50 1.00 5.00 10.00 50.00 100.00Organics, Method 1625: T= 1000Organics, 1000 DIBENZOFURAN, NG/ ULDIBENZOFURAN, UL 0.050.505.0050.00 0.05 0.10 0.50 1.00 5.00 10.00 50.00 100.00Organics, Method 1625: T= 1000Organics, 1000 DIBENZOTHIOPHENE, NG/ ULDIBENZOTHIOPHENE, UL 0.050.505.0050.00 0.05 0.10 0.50 1.00 5.00 10.00 50.00 100.00Organics, Method 1625: T= 1000Organics, 1000 DIETHYL PHTHALATE, NG/ ULDIETHYL UL 0.050.505.0050.00 0.1 0.5 1.0 5.0 10.0 50.0 100.0Organics, Method 1625: T= 1000Organics, 1000 DIMETHYL PHTHALATE, NG/ ULDIMETHYL UL 0.050.505.0050.00 0.05 0.10 0.50 1.00 5.00 10.00 50.00 100.00Organics, Method 1625: T= 1000Organics, 1000 DIPHENYL ETHER, NG/ ULDIPHENYL UL 10^ 410^ 310^ 210^ 110^ 010^ 110^ 2 0.1 0.5 1.0 5.0 10.0 50.0 100.0Organics, Method 1625: T= 1000Organics, 1000 DIPHENYLAMINE, NG/ ULDIPHENYLAMINE, UL 0.050.505.0050.00 0.05 0.10 0.50 1.00 5.00 10.00 50.00 100.00Organics, Method 1625: T= 1000Organics, 1000 FLUORANTHENE, NG/ ULFLUORANTHENE, UL 0.050.505.0050.00 0.05 0.10 0.50 1.00 5.00 10.00 50.00 100.00Organics, Method 1625: T= 1000Organics, 1000 FLUORENE, NG/ ULFLUORENE, UL 10^ 410^ 310^ 210^ 110^ 010^ 110^ 2 0.05 0.10 0.50 1.00 5.00 10.00 50.00 100.00Organics, Method 1625: T= 1000Organics, 1000 HEXACHLOROBENZENE, NG/ ULHEXACHLOROBENZENE, UL 0.050.505.0050.00 0.05 0.10 0.50 1.00 5.00 10.00 50.00 100.00Organics, Method 1625: T= 1000Organics, 1000 HEXACHLOROBUTADIENE, NG/ ULHEXACHLOROBUTADIENE, UL 0.050.505.0050.00 0.05 0.10 0.50 1.00 5.00 10.00 50.00 100.00Organics, Method 1625: T= 1000Organics, 1000 HEXACHLOROCYCLOPENTADIENE, NG/ ULHEXACHLOROCYCLOPENTADIENE, UL Episode 6000 Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

100.0 50.0 10.0 5.0 1.0 0.5 0.1 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 1000Organics, 1000 HEXACHLOROETHANE, NG/ ULHEXACHLOROETHANE, UL 100.0 50.0 10.0 5.0 1.0 0.5 0.1 0.05 0.50 5.00 50.00 Organics, Method 1625: T= 1000Organics, 1000 N DECANE, NG/ ULN UL 100.00 10.00 1.00 0.10 0.01 Organics, Method 1625: T= 1000Organics, 1000 N EICOSANE, NG/ ULN UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.05 0.50 5.00 50.00 Organics, Method 1625: T= 1000Organics, 1000 N NITROSODIMETHYLAMINE, NG/ ULN UL Mon Mar 18 16: 46: 33 2002 100.0 50.0 10.0 5.0 1.0 0.5 0.1 0.05 0.50 5.00 50.00 Organics, Method 1625: T= 1000Organics, 1000 INDENO( 1,2,3 CD) PYRENE, NG/ ULINDENO( UL 100.000 10.000 1.000 0.100 0.010 0.001 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 1000Organics, 1000 N DOCOSANE, NG/ ULN UL 100.00 10.00 1.00 0.10 0.01 Organics, Method 1625: T= 1000Organics, 1000 N HEXACOSANE, NG/ ULN UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 100.0 50.0 10.0 5.0 1.0 0.5 0.1 Organics, Method 1625: T= 1000Organics, 1000 N NITROSODIPHENYLAMINE, NG/ ULN UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Log 10 of Spike Concentration 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.05 0.50 5.00 50.00 Page 30 of 32 Organics, Method 1625: T= 1000Organics, 1000 ISOPHORONE, NG/ ULISOPHORONE, UL 100.0 10.0 1.0 0.1 Organics, Method 1625: T= 1000Organics, 1000 N DODECANE, NG/ ULN UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 100.00 10.00 1.00 0.10 0.01 Organics, Method 1625: T= 1000Organics, 1000 N HEXADECANE, NG/ ULN UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 100.0 10.0 1.0 0.1 Organics, Method 1625: T= 1000Organics, 1000 N OCTACOSANE, NG/ ULN UL 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 c:/ pw/ ostmdl/ req004/ r004sd1. s Log 10 of Measured Concentration Episode 6000 Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

100.000 10.000 1.000 0.100 0.010 0.001 10^ 4 100.00 10.00 1.00 0.10 0.01 10^ 4 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 0.05 100.00 50.00 10.00 5.00 1.00 0.50 0.10 0.05 Organics, Method 1625: T= 1000Organics, 1000 N OCTADECANE, NG/ ULN UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 1000Organics, 1000 N TRIACONTANE, NG/ ULN UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 1000Organics, 1000 P CYMENE, NG/ ULP UL 0.50 5.00 50.00 Organics, Method 1625: T= 1000Organics, 1000 PHENOL, NG/ ULPHENOL, UL 0.05 0.50 5.00 50.00 Organics, Method 1625: T= 1000Organics, 1000 N TETRACOSANE, NG/ ULN UL 100.0 50.0 10.0 10.0 5.0 1.0 1.0 0.1 0.5 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 10^ 4 100.00 Organics, Method 1625: T= 1000Organics, 1000 NAPHTHALENE, NG/ ULNAPHTHALENE, UL 100.0 10.00 10.0 1.00 1.0 0.10 0.1 0.01 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 10^ 4 100.0 Organics, Method 1625: T= 1000Organics, 1000 PENTACHLOROPHENOL, NG/ ULPENTACHLOROPHENOL, UL 100.00 50.0 50.00 10.0 10.00 5.0 5.00 1.00 1.0 0.50 0.5 0.10 0.1 0.05 0.05 0.50 5.00 50.00 0.05 100.00 Organics, Method 1625: T= 1000Organics, 1000 PHENOL, 2 METHYL 4,6 DINITRO, NG/ ULPHENOL, UL 100.00 50.00 10.00 10.00 5.00 1.00 1.00 0.10 0.50 0.010.10 0.05 0.05 0.50 5.00 50.00 10^ 4 Log 10 of Spike Concentration Page 31 of 32 Organics, Method 1625: T= 1000Organics, 1000 N TETRADECANE, NG/ ULN UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 1000Organics, 1000 NITROBENZENE, NG/ ULNITROBENZENE, UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Organics, Method 1625: T= 1000Organics, 1000 PHENANTHRENE, NG/ ULPHENANTHRENE, UL 0.50 5.00 50.00 Organics, Method 1625: T= 1000Organics, 1000 PYRENE, NG/ ULPYRENE, UL 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 c:/ pw/ ostmdl/ req004/ r004sd1. s Log 10 of Measured Concentration Mon Mar 18 16: 46: 47 2002 Episode 6000 Data Page 32 of 32 Measurement Results vs Spike Concentrations ( Log 10 Scale)

100.00 10.00 Organics, Method 1625: T= 1000Organics, 1000 STYRENE, NG/ ULSTYRENE, UL 1.00 0.10 0.01 10^ 4 10^ 3 10^ 2 10^ 1 10^ 0 10^ 1 10^ 2 Log 10 of Measured Concentration Mon Mar 18 16: 47: 01 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req004/ r004sd1. s Log

10 of Measured Concentration AAMA Metals Data APPENDIX B  2  2 Page 1 of 13 Measurement Results vs Spike Concentrations ( Log 10 Scale)

( Matrix A, Method EPA 200.7 ICP/ AES) 500.0500 500 100.0 50.0 100 Lab: 1Lab: 1 ALUMINUM, UG/

LALUMINUM, L 100 10.0 50 Lab: 2Lab: 2 ALUMINUM, UG/

LALUMINUM, L 5.0 50 1.0 10 0.5 Lab: 3Lab: 3 ALUMINUM, UG/

LALUMINUM, L 0.1 1.0 10.0 100.0 0.1 1.0 10.0 100.0 0.1 1.0 10.0 100.0 600 1000 500 Lab: 5Lab: 5 ALUMINUM, UG/

LALUMINUM, L 500 500 Lab: 4Lab: 4 ALUMINUM, UG/

LALUMINUM, L 400 300 200 100 100 50 50 100 90 Lab: 6Lab: 6 ALUMINUM, UG/

LALUMINUM, L 0.1 1.0 10.0 100.0 0.1 1.0 10.0 100.0 0.1 1.0 10.0 100.0 500 Lab: 7Lab: 7 ALUMINUM, UG/

LALUMINUM, L 500 500 100 50 Lab: 8Lab: 8 ALUMINUM, UG/

LALUMINUM, L 100 50 100 10 5 5 50 10 Lab: 9Lab: 9 ALUMINUM, UG/

LALUMINUM, L 50 100 500 5 10 50 100 500 0.1 1.0 10.0 100.0 Log 10 of Spike Concentration Log

10 of Measured Concentration AAMA Metals Data Page 2 of 13 Measurement Results vs Spike Concentrations ( Log 10 Scale)

( Matrix A, Method EPA 200.7 ICP/ AES)

500 Lab: 1Lab: 1 ARSENIC, UG/

LARSENIC, L Lab: 2Lab: 2 ARSENIC, UG/

LARSENIC, L 500 500 100 100 50 50 100 10 50 5 10 5 1 Lab: 3Lab: 3 ARSENIC, UG/

LARSENIC, L 0.1 1.0 10.0 100.0 0.1 1.0 10.0 100.0 0.1 1.0 10.0 100.0 500 Lab: 4Lab: 4 ARSENIC, UG/

LARSENIC, L Lab: 5Lab: 5 ARSENIC, UG/

LARSENIC, L 500 100.0 100 100 5010.0 50 Lab: 6Lab: 6 ARSENIC, UG/

LARSENIC, L 1.0 10 10 5 5 0.1 5 10 50 100 500 5 10 50 100 500 0.1 1.0 10.0 100.0 500 Lab: 7Lab: 7 ARSENIC, UG/

LARSENIC, L 500 100.0 100 50 100 10.0 50 10 5 Lab: 8Lab: 8 ARSENIC, UG/

LARSENIC, L 1.0 10 1 5 0.1 Lab: 9Lab: 9 ARSENIC, UG/

LARSENIC, L 5 10 50100 500 5 10 50100 500 5 10 50100 500 Tue Mar 26 17: 16: 51 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req005/ r005sd1. s Log

10 of Measured Concentration AAMA Metals Data Page 3 of 13 Measurement Results vs Spike Concentrations ( Log 10 Scale)

( Matrix A, Method EPA 200.7 ICP/ AES) 100100 Lab: 1Lab: 1 CADMIUM, UG/

LCADMIUM, L 100 50 Lab: 2Lab: 2 CADMIUM, UG/

LCADMIUM, L 50 50 10 10 10 55 5 11 1 5 10 50100 1 5 10 50100 1 5 10 50100 Lab: 3Lab: 3 CADMIUM, UG/

LCADMIUM, L 100.0 Lab: 4Lab: 4 CADMIUM, UG/

LCADMIUM, L 100.0 Lab: 5Lab: 5 CADMIUM, UG/

LCADMIUM, L 100 50.0 50.0 50 10.0 10.0 10 5.0 5.0 5 1.0 1.0 0.5 0.5 1 1 5 10 50 100 1 5 10 50 100 0.1 0.5 1.0 5.0 10.0 50.0 Lab: 6Lab: 6 CADMIUM, UG/

LCADMIUM, L 100 Lab: 7Lab: 7 CADMIUM, UG/

LCADMIUM, L 100 Lab: 8Lab: 8 CADMIUM, UG/

LCADMIUM, L 100 50 50 50 10 10 10 55 5 111 0.1 0.5 1.0 5.010.0 50.0 1 5 10 50 100 1 5 10 50 100 Lab: 9Lab: 9 CADMIUM, UG/

LCADMIUM, L Tue Mar 26 17: 16: 54 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req005/ r005sd1. s Log

10 of Measured Concentration AAMA Metals Data Page 4 of 13 Measurement Results vs Spike Concentrations ( Log 10 Scale)

( Matrix A, Method EPA 200.7 ICP/ AES)

Lab: 1Lab: 1 CHROMIUM, UG/

LCHROMIUM, L 100.0 Lab: 2Lab: 2 CHROMIUM, UG/

LCHROMIUM, L 100 100 50.0 50 50 10.0 5.0 10 10 5 1.0 5 0.5 1 Lab: 3Lab: 3 CHROMIUM, UG/

LCHROMIUM, L 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 5 10 50 100 100 Lab: 5Lab: 5 CHROMIUM, UG/

LCHROMIUM, L 100 100 50 50 50 10 10 5 10 Lab: 4Lab: 4 CHROMIUM, UG/

LCHROMIUM, L 5 51 Lab: 6Lab: 6 CHROMIUM, UG/

LCHROMIUM, L 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 100 Lab: 7Lab: 7 CHROMIUM, UG/

LCHROMIUM, L 100 Lab: 8Lab: 8 CHROMIUM, UG/

LCHROMIUM, L 100 50 50 50 10 10 10 5 5 5 Lab: 9Lab: 9 CHROMIUM, UG/

LCHROMIUM, L 5 10 50100 5 10 50100 5 10 50100 Tue Mar 26 17: 16: 56 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req005/ r005sd1. s Log

10 of Measured Concentration AAMA Metals Data Page 5 of 13 Measurement Results vs Spike Concentrations ( Log 10 Scale)

( Matrix A, Method EPA 200.7 ICP/ AES)

100.0 100.0 100 50.0 50.0 50 10.0 10.0 5.0 5.0 10 5 1.0 1.0 0.5 0.5 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 Lab: 2Lab: 2 COPPER, UG/ LCOPPER, L Lab: 3Lab: 3 COPPER, UG/ LCOPPER, L Lab: 1Lab: 1 COPPER, UG/ LCOPPER, L 100 Lab: 5Lab: 5 COPPER, UG/ LCOPPER, L 100 100 50 50 50 10 10 Lab: 4Lab: 4 COPPER, UG/ LCOPPER, L 10 5 55 1 Lab: 6Lab: 6 COPPER, UG/ LCOPPER, L 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 100 Lab: 7Lab: 7 COPPER, UG/ LCOPPER, L 100 Lab: 8Lab: 8 COPPER, UG/ LCOPPER, L 100 50 50 50 10 10 10 55 5 1 5 10 50 100 5 10 50 100 0.1 0.5 1.0 5.0 50.0 Lab: 9Lab: 9 COPPER, UG/ LCOPPER, L Tue Mar 26 17: 16: 59 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req005/ r005sd1. s Log

10 of Measured Concentration AAMA Metals Data Page 6 of 13 Measurement Results vs Spike Concentrations ( Log 10 Scale)

( Matrix A, Method EPA 200.7 ICP/ AES)

500 Lab: 1Lab: 1 LEAD, UG/ LLEAD, L 500 Lab: 2Lab: 2 LEAD, UG/ LLEAD, L 500 100 100 100 50 50 50 10 10 55 10 15 1 Lab: 3Lab: 3 LEAD, UG/ LLEAD, L 5 10 50 100 500 0.1 1.0 10.0 100.0 0.1 1.0 10.0 100.0 500 Lab: 5Lab: 5 LEAD, UG/ LLEAD, L 500 500 100 100 100 Lab: 4Lab: 4 LEAD, UG/ LLEAD, L 50 50 50 Lab: 6Lab: 6 LEAD, UG/ LLEAD, L 10 10 10 5 5 5 0.1 1.0 10.0 100.0 0.1 1.0 10.0 100.0 0.1 1.0 10.0 100.0 500 Lab: 7Lab: 7 LEAD, UG/ LLEAD, L 500 Lab: 8Lab: 8 LEAD, UG/ LLEAD, L 500 100 100 100 50 50 50 10 10 10 55 5 Lab: 9Lab: 9 LEAD, UG/ LLEAD, L 0.1 1.0 10.0 100.0 5 10 50 100 500 0.1 1.0 10.0 100.0 Tue Mar 26 17: 17: 01 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req005/ r005sd1. s Lab: 4Lab: 4 MANGANESE, UG/ LMANGANESE, L Log

10 of Measured Concentration AAMA Metals Data Page 7 of 13 Measurement Results vs Spike Concentrations ( Log 10 Scale)

( Matrix A, Method EPA 200.7 ICP/ AES)

50 Lab: 1Lab: 1 MANGANESE, UG/ LMANGANESE, L 50 Lab: 2Lab: 2 MANGANESE, UG/ LMANGANESE, L 50.0 Lab: 3Lab: 3 MANGANESE, UG/ LMANGANESE, L 10.0 10 5.0 10 5 1.0 5 0.5 1 0.1 0.5 1.0 5.0 10.0 50.0 5 10 50 0.5 1.0 5.0 10.0 50.0 50.0 50.0 Lab: 5Lab: 5 MANGANESE, UG/ LMANGANESE, L 50.0 10.0 10.0 10.0 5.05.0 5.0 1.0 1.0 1.0 0.5 0.5 0.5 Lab: 6Lab: 6 MANGANESE, UG/ LMANGANESE, L 0.1 0.5 1.0 5.0 10.0 50.0 0.1 0.5 1.0 5.0 10.0 50.0 0.1 0.5 1.0 5.0 10.0 50.0 50.0 Lab: 7Lab: 7 MANGANESE, UG/ LMANGANESE, L 50.0 10.00 10.0 10.0 1.00 5.0 5.0 0.10 1.0 1.0 0.5 Lab: 8Lab: 8 MANGANESE, UG/ LMANGANESE, L 0.01 0.5 0.5 1.0 5.0 10.0 50.0 0.5 1.0 5.0 10.0 50.0 0.1 0.5 1.0 5.0 10.0 50.0 Lab: 9Lab: 9 MANGANESE, UG/ LMANGANESE, L Tue Mar 26 17: 17: 04 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req005/ r005sd1. s Log

10 of Measured Concentration AAMA Metals Data Page 8 of 13 Measurement Results vs Spike Concentrations ( Log 10 Scale)

( Matrix A, Method EPA 245 CVA)

1.00 Lab: 1Lab: 1 MERCURY, UG/

LMERCURY, L 1.00 Lab: 2Lab: 2 MERCURY, UG/

LMERCURY, L 1.00 0.50 0.50 0.50 0.10 0.10 0.10 0.050.05 0.05 0.01 0.01 Lab: 3Lab: 3 MERCURY, UG/

LMERCURY, L 0.01 0.05 0.10 0.50 1.00 0.01 0.05 0.10 0.50 1.00 0.01 0.05 0.10 0.50 1.00 10.00 1.00 Lab: 4Lab: 4 MERCURY, UG/

LMERCURY, L 1.00 Lab: 5Lab: 5 MERCURY, UG/

LMERCURY, L 5.00 0.50 0.50 1.00 Lab: 6Lab: 6 MERCURY, UG/

LMERCURY, L 0.10 0.10 0.50 0.05 0.05 0.10 0.01 0.01 0.05 0.001 0.005 0.050 0.500 0.001 0.005 0.050 0.500 0.001 0.005 0.050 0.500 1.000 1.00 Lab: 8Lab: 8 MERCURY, UG/

LMERCURY, L 1.00 0.500 0.50 0.50 0.100 0.050 Lab: 7Lab: 7 MERCURY, UG/

LMERCURY, L 0.10 0.10 0.05 0.010 0.05 0.005 0.01 0.05 0.10 0.50 1.00 0.01 0.05 0.10 0.50 1.00 0.001 0.005 0.050 0.500 Lab: 9Lab: 9 MERCURY, UG/

LMERCURY, L Tue Mar 26 17: 17: 07 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req005/ r005sd1. s Log

10 of Measured Concentration AAMA Metals Data Page 9 of 13 Measurement Results vs Spike Concentrations ( Log 10 Scale)

( Matrix A, Method EPA 200.7 ICP/ AES)

100 100 50 50 10 Lab: 1Lab: 1 MOLYBDENUM, UG/

LMOLYBDENUM, L Lab: 2Lab: 2 MOLYBDENUM, UG/

LMOLYBDENUM, L 5.0 5 1.0 10 0.5 0.1 0.5 1.0 5.0 50.0 5 10 50 100 0.1 0.5 1.0 5.0 50.0 10.0 50.0 100.0 Lab: 3Lab: 3 MOLYBDENUM, UG/

LMOLYBDENUM, L 100 50 50 10 10.0 50.0 100.0 Lab: 4Lab: 4 MOLYBDENUM, UG/

LMOLYBDENUM, L 5.0 10 5 Lab: 5Lab: 5 MOLYBDENUM, UG/

LMOLYBDENUM, L 5 1.0 0.5 1 100 Lab: 6Lab: 6 MOLYBDENUM, UG/

LMOLYBDENUM, L 5 10 50 100 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 Lab: 7Lab: 7 MOLYBDENUM, UG/

LMOLYBDENUM, L 100 100 50 Lab: 8Lab: 8 MOLYBDENUM, UG/

LMOLYBDENUM, L 50 50 10 10 10 5 5 5 11 100 Lab: 9Lab: 9 MOLYBDENUM, UG/

LMOLYBDENUM, L 5 10 50 100 5 10 50 100 0.1 0.5 1.0 5.0 50.0 Tue Mar 26 17: 17: 10 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req005/ r005sd1. s Log

10 of Measured Concentration AAMA Metals Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

( Matrix A, Method EPA 200.7 ICP/ AES)

Lab: 1Lab: 1 NICKEL, UG/

LNICKEL, L 100 100 50 50 10 5.0 5 10 1.0 5 1 Lab: 2Lab: 2 NICKEL, UG/

LNICKEL, L 0.5 Page 10 of 13 10.0 50.0 100.0 Lab: 3Lab: 3 NICKEL, UG/

LNICKEL, L 5 10 50 100 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 100 100 50 50 Lab: 4Lab: 4 NICKEL, UG/

LNICKEL, L Lab: 5Lab: 5 NICKEL, UG/

LNICKEL, L 50 10 10 5 5 100 500 1000 Lab: 6Lab: 6 NICKEL, UG/

LNICKEL, L 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 100 Lab: 7Lab: 7 NICKEL, UG/

LNICKEL, L 100 50 50 50 10 5 10 10 5 1 Lab: 8Lab: 8 NICKEL, UG/

LNICKEL, L 5 100 Lab: 9Lab: 9 NICKEL, UG/

LNICKEL, L 5 10 50100 5 10 50100 5 10 50100 Tue Mar 26 17: 17: 13 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req005/ r005sd1. s Log

10 of Measured Concentration AAMA Metals Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

( Matrix A, Method EPA 200.7 ICP/ AES)

1000 Lab: 1Lab: 1 SELENIUM, UG/

LSELENIUM, L 1000 Lab: 2Lab: 2 SELENIUM, UG/

LSELENIUM, L 1000.0 500 500.0 500 100.0 100 50.0 50100 Page 11 of 13 Lab: 3Lab: 3 SELENIUM, UG/

LSELENIUM, L 50 10.0 10 5.0 5 10 1.0 1 0.5 10 50 100 500 1000 10 50 100 500 1000 0.1 1.0 10.0 100.0 1000.0 1000 Lab: 4Lab: 4 SELENIUM, UG/

LSELENIUM, L 1000 Lab: 5Lab: 5 SELENIUM, UG/

LSELENIUM, L 1000 500 500 100 100 50 100 10 50 10 5 1 10 1 10 50 100 500 1000 0.1 1.0 10.0 100.0 1000.0 0.1 1.0 10.0 100.0 1000.0 Lab: 6Lab: 6 SELENIUM, UG/

LSELENIUM, L 1000 Lab: 7Lab: 7 SELENIUM, UG/

LSELENIUM, L 1000 1000 500 500 500 100 100 50 50 Lab: 8Lab: 8 SELENIUM, UG/

LSELENIUM, L 100 50 10 10 55 10 10 50 100 500 1000 0.1 1.0 10.0 100.0 1000.0 0.1 1.0 10.0 100.0 1000.0 Lab: 9Lab: 9 SELENIUM, UG/

LSELENIUM, L Tue Mar 26 17: 17: 16 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req005/ r005sd1. s Log

10 of Measured Concentration AAMA Metals Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

( Matrix A, Method EPA 200.7 ICP/ AES)

100 Lab: 1Lab: 1 SILVER, UG/ LSILVER, L 100.0 Lab: 2Lab: 2 SILVER, UG/ LSILVER, L 100.0 50.0 50.0 50 10.0 10.0 5.0 10 5.0 5 1.0 1.0 0.5 0.5 1 Page 12 of 13 Lab: 3Lab: 3 SILVER, UG/ LSILVER, L 0.1 0.5 1.0 5.0 10.0 50.0 0.5 1.0 5.0 10.0 50.0 0.1 0.5 1.0 5.0 10.0 50.0 100.0 50.0 100.0 100 50.0 50 Lab: 4Lab: 4 SILVER, UG/ LSILVER, L 10.0 5.0 Lab: 5Lab: 5 SILVER, UG/ LSILVER, L 10.0 5.0 1.0 10 0.5 1.0 0.5 5 0.1 0.1 0.5 1.0 5.0 10.0 50.0 0.1 0.5 1.0 5.0 10.0 50.0 0.1 0.5 1.0 5.0 10.0 50.0 Lab: 6Lab: 6 SILVER, UG/ LSILVER, L 100 Lab: 7Lab: 7 SILVER, UG/ LSILVER, L 100 Lab: 8Lab: 8 SILVER, UG/ LSILVER, L 100.00 50 50 10.00 1.00 10 10 5 5 0.10 0.01 11 0.1 0.5 1.0 5.0 10.0 50.0 0.5 1.0 5.0 10.0 50.0 0.1 0.5 1.0 5.0 10.0 50.0 Lab: 9Lab: 9 SILVER, UG/ LSILVER, L Tue Mar 26 17: 17: 19 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req005/ r005sd1. s Log

10 of Measured Concentration AAMA Metals Data Measurement Results vs Spike Concentrations ( Log 10 Scale)

( Matrix A, Method EPA 200.7 ICP/ AES)

100 Lab: 2Lab: 2 ZINC, UG/ LZINC, L 100 100 50 50 50 10 10 10 Lab: 1Lab: 1 ZINC, UG/ LZINC, L 5 5 5 1 Page 13 of 13 Lab: 3Lab: 3 ZINC, UG/ LZINC, L 0.1 0.5 1.0 5.0 50.0 5 10 50 100 0.1 0.5 1.0 5.0 50.0 100 Lab: 5Lab: 5 ZINC, UG/ LZINC, L 100 100 Lab: 4Lab: 4 ZINC, UG/ LZINC, L 50 50 50 10 10 5 10 5 5 Lab: 6Lab: 6 ZINC, UG/ LZINC, L 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 100.0 100 50.0 100 Lab: 7Lab: 7 ZINC, UG/ LZINC, L 50 10.0 5.0 50 10 1.0 5 Lab: 8Lab: 8 ZINC, UG/ LZINC, L 0.5 0.1 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 0.1 0.5 1.0 5.0 50.0 Lab: 9Lab: 9 ZINC, UG/ LZINC, L Tue Mar 26 17: 17: 21 2002 Log 10 of Spike Concentration c:/ pw/ ostmdl/ req005/ r005sd1. s


[Federal Register Volume 86, Number 130 (Monday, July 12, 2021)]
[Rules and Regulations]
[Pages 36487-36491]
[FR Doc No: 2021-14701]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2021-0022; Project Identifier MCAI-2020-00395-E;
Amendment 39-21648; AD 2021-15-01]
RIN 2120-AA64

Airworthiness Directives; Rolls-Royce Deutschland Ltd & Co KG
(Type Certificate Previously Held by Rolls-Royce plc) Turbofan Engines

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The FAA is adopting a new airworthiness directive (AD) for all
Rolls-Royce Deutschland Ltd & Co KG (RRD) Trent XWB-75, Trent XWB-79,
Trent XWB-79B, Trent XWB-84, and Trent XWB-97 model turbofan engines.
This AD was prompted by the manufacturer revising the time limits

manual (TLM) to incorporate repairs to the low-pressure compressor
(LPC) blades and introduce a new fan blade inspection. This AD requires
revisions to the airworthiness limitations section (ALS) of the Rolls-
Royce (RR) Trent XWB TLM and the operator's existing approved aircraft
maintenance program (AMP). The FAA is issuing this AD to address the
unsafe condition on these products.

DATES: This AD is effective August 16, 2021.

ADDRESSES: For service information identified in this final rule,
contact Rolls-Royce plc, Corporate Communications, P.O. Box 31, Derby,
DE24 8BJ, United Kingdom; phone: +44 (0)1332 242424; website: https://www.rolls-royce.com/contact-us.aspx. You may view this service
information at the FAA, Airworthiness Products Section, Operational
Safety Branch, 1200 District Avenue, Burlington, MA 01803. For
information on the availability of this material at the FAA, call (781)
238-7759. It is also available at https://www.regulations.gov by
searching for and locating Docket No. FAA-2021-0022.

Examining the AD Docket

    You may examine the AD docket at https://www.regulations.gov by
searching for and locating Docket No. FAA-2021-0022; or in person at
Docket Operations between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The AD docket contains this final rule, the
mandatory continuing airworthiness information (MCAI), any comments
received, and other information. The address for Docket Operations is
U.S. Department of Transportation, Docket Operations, M-30, West
Building Ground Floor, Room W12-140, 1200 New Jersey Avenue SE,
Washington, DC 20590.

FOR FURTHER INFORMATION CONTACT: Scott Stevenson, Aviation Safety
Engineer, ECO Branch, FAA, 1200 District Avenue, Burlington, MA 01803;
phone:<PHONE_NUMBER>; fax:<PHONE_NUMBER>; email:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

Background

    The FAA issued a notice of proposed rulemaking (NPRM) to amend 14
CFR part 39 by adding an AD that would apply to all RRD Trent XWB-75,
Trent XWB-79, Trent XWB-79B, Trent XWB-84, and Trent XWB-97 model
turbofan engines. The NPRM published in the Federal Register on
February 23, 2021 (86 FR 10878). The NPRM was prompted by the
manufacturer revising the TLM to incorporate repairs to the LPC blades
and introduce a new fan blade inspection. In the NPRM, the FAA proposed
to require revisions to the ALS of the RR Trent XWB TLM, as applicable
to each engine model, and to the operator's existing approved AMP, to
include new or more restrictive sections of the applicable RR Trent XWB
TLM for each affected engine model. The FAA is issuing this AD to
address the unsafe condition on these products.
    The European Union Aviation Safety Agency (EASA), which is the
Technical Agent for the Member States of the European Community, has
issued EASA AD 2020-0066, dated March 23, 2020 (referred to after this
as ``the MCAI''), to address the unsafe condition on these products.
The MCAI states:

    The Airworthiness Limitations Section instructions for Trent XWB
engines, which are approved by EASA, are defined and published in
TLM TRENTXWB-K0680-TIME0-01. These instructions have been identified
as mandatory for continued airworthiness. Failure to accomplish
these instructions could result in an unsafe condition.
    Rolls-Royce recently revised the TLM, introducing new and/or
more restrictive instructions.
    For the reason described above, this [EASA] AD requires
accomplishment of the instructions specified in the TLM, as defined
in this AD.

    You may obtain further information by examining the MCAI in the AD
docket at https://www.regulations.gov by searching for and locating
Docket No. FAA-2021-0022.

Discussion of Final Airworthiness Directive Comments

    The FAA received comments from two commenters. The commenters were
Air Line Pilots Association, International (ALPA) and Delta Air Lines,
Inc. (DAL). The following presents the comments received on the NPRM
and the FAA's response to each comment.

Request To Revise Required Actions

    DAL commented that revising the AMP to include the specific
requirements contained in Figure 1 to paragraph (g)(1) or Figure 2 to
paragraph (g)(2) is difficult. DAL requested that the FAA revise
paragraph (g) of this AD to allow incorporation of the specific
language referenced in Figure 1 to paragraph (g)(1) or Figure 2 to
paragraph (g)(2) into the AMP instead of only allowing incorporation of
the figures into the AMP.
    The FAA agrees and has revised Note 1 to paragraph (g) of this AD
to clarify that operators may choose to incorporate the language
referenced in Figure 1 to paragraph (g)(1) or Figure 2 to paragraph
(g)(2) directly into their existing approved AMP instead of
incorporating the respective figures into the existing approved AMP.

Request To Include Modification Specifications of the Ultra Long Range
Operation

    DAL noted that paragraph (g)(1) of the NPRM includes a proposed
requirement that applies to Trent XWB-84 Ultra Long Range (ULR)
operation. However, the RR Trent XWB TLM does not define the
specification of a ULR operation. DAL commented that ULR operation
requires modification to the airplane. The Trent XWB-84 can be
installed on both A350-900 standard or ULR operations without any
modification to the engine. DAL added that the airplane type
certification data sheet does not specify the modification standards of
a ULR operation. Since the TLM does not include any specifications of
ULR operation and the aircraft type certificate data sheet does not
define this specific standard, DAL requested that the FAA include the
modification specifications of the ULR operation in the final rule.
    The FAA disagrees. Although the airplane requires modification for
ULR operation, the Trent XWB-84 model turbofan engine does not require
modification for ULR operation and can be installed on a standard
airplane or a ULR airplane. The FAA did not change this AD.

Support for the AD

    ALPA expressed support for the NPRM as written.

Conclusion

    The FAA reviewed the relevant data, considered any comments
received, and determined that air safety requires adopting this AD as
proposed. Accordingly, the FAA is issuing this AD to address the unsafe
condition on these products. Except for minor editorial changes, and
any other changes described previously, this AD is adopted as proposed
in the NPRM. None of the changes will increase the economic burden on
any operator.

Related Service Information

    The FAA reviewed Rolls-Royce Airworthiness Limitations (Mandatory
Inspections), TRENTXWB-A-05-20-01-00A01-030A-D, Revision 013, dated
September 1, 2019, of the Rolls-Royce Trent XWB TLM TRENTXWB-K0680-
TIME0-01, and Rolls-Royce Airworthiness Limitations (Mandatory
Inspections), TRENTXWB-B-05-20-01-00A01-030A-D, Revision 005, dated

April 1, 2020, of the Rolls-Royce Trent XWB TLM TRENTXWB-K0680-TIME0-
01. These two sections of the TLM specify inspection intervals,
differentiated by engine model, for critical rotating parts.

Costs of Compliance

    The FAA estimates that this AD affects 22 engines installed on
airplanes of U.S. registry.
    The FAA estimates the following costs to comply with this AD:

                                                 Estimated Costs
----------------------------------------------------------------------------------------------------------------
                                                                                Cost per      Cost on U.S.
                Action                         Labor cost           Parts cost        product        operators
----------------------------------------------------------------------------------------------------------------
Revise the ALS of the RR Trent XWB TLM  1 work-hour x $85 per                 $0             $85          $1,870
 and the operator's existing approved    hour = $85.
 AMP.
----------------------------------------------------------------------------------------------------------------

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. Subtitle VII: Aviation Programs,
describes in more detail the scope of the Agency's authority.
    The FAA is issuing this rulemaking under the authority described in
Subtitle VII, Part A, Subpart III, Section 44701: General requirements.
Under that section, Congress charges the FAA with promoting safe flight
of civil aircraft in air commerce by prescribing regulations for
practices, methods, and procedures the Administrator finds necessary
for safety in air commerce. This regulation is within the scope of that
authority because it addresses an unsafe condition that is likely to
exist or develop on products identified in this rulemaking action.

Regulatory Findings

    This AD will not have federalism implications under Executive Order
13132. This AD will not have a substantial direct effect on the States,
on the relationship between the national government and the States, or
on the distribution of power and responsibilities among the various
levels of government.
    For the reasons discussed above, I certify this AD:
    (1) Is not a ``significant regulatory action'' under Executive
Order 12866,
    (2) Will not affect intrastate aviation in Alaska, and
    (3) Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

Adoption of the Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA amends 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority:  49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by adding the following new airworthiness
directive:

2021-15-01 Rolls-Royce Deutschland Ltd & Co KG (Type Certificate
previously held by Rolls-Royce plc): Amendment 39-21648; Docket No.
FAA-2021-0022; Project Identifier MCAI-2020-00395-E.

(a) Effective Date

    This airworthiness directive (AD) is effective August 16, 2021.

(b) Affected ADs

    None.

(c) Applicability

    This AD applies to Rolls-Royce Deutschland Ltd & Co KG (RRD)
(Type Certificate previously held by Rolls-Royce plc) Trent XWB-75,
Trent XWB-79, Trent XWB-79B, Trent XWB-84, and Trent XWB-97 model
turbofan engines.

(d) Subject

    Joint Aircraft System Component (JASC) Code 7200, Engine
Turbine/Turboprop.

(e) Unsafe Condition

    This AD was prompted by the manufacturer revising the time
limits manual (TLM) to incorporate repairs to the low-pressure
compressor (LPC) blades and introduce a new fan blade inspection.
The FAA is issuing this AD to prevent the failure of critical
rotating parts. The unsafe condition, if not addressed, could result
in failure of one or more engines, loss of thrust control, and loss
of the airplane.

(f) Compliance

    Comply with this AD within the compliance times specified,
unless already done.

(g) Required Actions

    Within 120 days after the effective date of this AD, revise the
Rolls-Royce (RR) Trent XWB TLM, as applicable to each engine model,
and the operator's existing approved aircraft maintenance program
(AMP) by incorporating the following:
    (1) For Trent XWB-75, Trent XWB-79, Trent XWB-79B, and Trent
XWB-84 model turbofan engines, add Figure 1 to paragraph (g)(1) of
this AD to the airworthiness limitations section (ALS) of RR Trent
XWB TLM TRENTXWB-K0680-TIME0-01 and to the operator's existing
approved AMP.

[GRAPHIC] [TIFF OMITTED] TR12JY21.000

    (2) For Trent XWB-97 model turbofan engines, add Figure 2 to
paragraph (g)(2) of this AD to the ALS of RR Trent XWB TLM TRENTXWB-
K0680-TIME0-01 and to the operator's existing approved AMP.
[GRAPHIC] [TIFF OMITTED] TR12JY21.001

    Note 1 to paragraph (g):  Figure 1 to paragraph (g)(1) and
Figure 2 to paragraph (g)(2) contain language from the original
equipment manufacturer's TLM. Operators may incorporate the language
referenced in Figure 1 to paragraph (g)(1) or Figure 2 to paragraph
(g)(2) directly into their AMP instead of adding the respective
figures into their AMP.

(h) Definition

    For the purpose of this AD, the operator's existing approved AMP
is defined as the basis for which the operator or the owner ensures
the continuing airworthiness of each operated airplane.

(i) Alternative Methods of Compliance (AMOCs)

    (1) The Manager, ECO Branch, FAA, has the authority to approve
AMOCs for this AD, if requested using the procedures found in 14 CFR
39.19. In accordance with 14 CFR 39.19, send your request to your
principal inspector or local Flight Standards District Office, as
appropriate. If sending information directly to the manager of the
ECO Branch, send it to the attention of the person identified in
Related Information. You may email your request to<EMAIL_ADDRESS>    (2) Before using any approved AMOC, notify your appropriate
principal inspector, or lacking a principal inspector, the manager
of the local flight standards district office/certificate holding
district office.

(j) Related Information

    (1) For more information about this AD, contact Scott Stevenson,
Aviation Safety Engineer, ECO Branch, FAA, 1200 District Avenue,
Burlington, MA 01803; phone:<PHONE_NUMBER>; fax:<PHONE_NUMBER>;
email<EMAIL_ADDRESS>    (2) Refer to European Union Aviation Safety Agency (EASA) AD
2020-0066, dated March 23, 2020, for more information. You may
examine the EASA AD in the AD docket

at https://www.regulations.gov by searching for and locating Docket
No. FAA-2021-0022.

(k) Material Incorporated by Reference

    None.

    Issued on July 6, 2021.
Gaetano A. Sciortino,
Deputy Director for Strategic Initiatives, Compliance & Airworthiness
Division, Aircraft Certification Service.
[FR Doc. 2021-14701 Filed 7-9-21; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 76, Number 3 (Wednesday, January 5, 2011)]
[Notices]
[Pages 611-612]
[FR Doc No: 2010-33255]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-63615; File No. SR-NYSEAmex-2010-123]

Self-Regulatory Organizations; NYSE Amex LLC; Notice of Filing
and Immediate Effectiveness of Proposed Rule Change Extending the
Operation of Its Supplemental Liquidity Providers Pilot Until the
Earlier of the Securities and Exchange Commission Approval To Make Such
Pilot Permanent or August 1, 2011

December 29, 2010.
    Pursuant to Section 19(b)(1) \1\ of the Securities Exchange Act of
1934 (the ``Act'') and Rule 19b-4 thereunder,\2\ notice is hereby given
that on December 20, 2010, NYSE Amex LLC (the ``Exchange'' or ``NYSE
Amex'') filed with the Securities and Exchange Commission (the
``Commission'') the proposed rule change as described in Items I and II
below, which Items have been prepared by the self-regulatory
organization. The Commission is publishing this notice to solicit
comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to extend the operation of its Supplemental
Liquidity Providers Pilot (``SLP Pilot'' or ``Pilot'') (See Rule 107B--
NYSE Amex Equities), currently scheduled to expire on January 31, 2011,
until the earlier of the Securities and Exchange Commission's (``SEC''
or ``Commission'') approval to make such Pilot permanent or August 1,
2011. The text of the proposed rule change is available at the
Exchange, the Commission's Public Reference Room, and http://www.nyse.com.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of those statements may be examined at
the places specified in Item IV below. The Exchange has prepared
summaries, set forth in sections A, B, and C below, of the most
significant parts of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange proposes to extend the operation of its Supplemental
Liquidity Providers Pilot,\3\ currently scheduled to expire on January
31, 2011, until the earlier of Commission approval to make such Pilot
permanent or August 1, 2011.
---------------------------------------------------------------------------

    \3\ See Securities Exchange Act Release No. 61308 (January 7,
2010), 75 FR 2573 (January 15, 2010) (SR-NYSEAmex-2009-98)
(establishing the NYSE Amex Equities SLP Pilot). See also Securities
Exchange Act Release Nos. 61841 (April 5, 2010), 75 FR 18560 (April
12, 2010) (SR-NYSEAmex-2010-33) (extending the operation of the SLP
Pilot to September 30, 2010); 62814 (September 1, 2010), 75 FR 54671
(September 8, 2010) (SR-NYSEAmex-2010-88) (extending the operation
of the SLP Pilot to January 31, 2011); 58877 (October 29, 2008), 73
FR 65904 (November 5, 2008) (SR-NYSE-2008-108) (establishing the SLP
Pilot); 59869 (May 6, 2009), 74 FR 22796 (May 14, 2009) (SR-NYSE-
2009-46) (extending the operation of the SLP Pilot to October 1,
2009); 60756 (October 1, 2009), 74 FR 51628 (October 7, 2009) (SR-
NYSE-2009-100) (extending the operation of the New Market Model and
the SLP Pilots to November 30, 2009); 61075 (November 30, 2009), 74
FR 64112 (December 7, 2009) (SR-NYSE-2009-119) (extending the
operation of the SLP Pilot to March 30, 2010); 61840 (April 5,
2010), 75 FR 18563 (April 12, 2010) (SR-NYSE-2010-28) (extending the
operation of the SLP Pilot to September 30, 2010); and 62813
(September 1, 2010), 75 FR 54686 (September 8, 2010) (SR-NYSE-2010-
62) (extending the operation of the SLP Pilot to January 31, 2011).
---------------------------------------------------------------------------

Background \4\
---------------------------------------------------------------------------

    \4\ The information contained herein is a summary of the NMM
Pilot and the SLP Pilot. See supra note 1 [sic] and infra [sic] note
3 for a fuller description of those pilots.
---------------------------------------------------------------------------

    In October 2008, the New York Stock Exchange LLC (``NYSE'')
implemented significant changes to its market rules, execution
technology and the rights and obligations of its market participants
all of which were designed to improve execution quality on the NYSE.
These changes were all elements of the NYSE's and the Exchange's
enhanced market model referred to as the ``New Market Model'' (``NMM
Pilot'').\5\ The NYSE SLP Pilot was launched in coordination with the
NMM Pilot (see NYSE Rule 107B).
---------------------------------------------------------------------------

    \5\ See Securities Exchange Act Release No. 58845 (October 24,
2008), 73 FR 64379 (October 29, 2008) (SR-NYSE-2008-46).
---------------------------------------------------------------------------

    As part of the NMM Pilot, NYSE eliminated the function of
specialists on the Exchange, creating a new category of market
participant, the Designated Market Maker or ``DMM.'' \6\ Separately,
the NYSE established the SLP Pilot, which established SLPs as a new
class of market participants to supplement the liquidity provided by
DMMs.\7\
---------------------------------------------------------------------------

    \6\ See NYSE Rule 103.
    \7\ See NYSE and NYSE Amex Equities Rules 107B.
---------------------------------------------------------------------------

    The NYSE adopted NYSE Rule 107B governing SLPs as a six-month pilot
program commencing in November 2008. This NYSE pilot has been extended
several times, most recently to January 31, 2011.\8\ The NYSE is in the
process of requesting an extension of their SLP Pilot until August 1,
2011 or until the Commission approves the pilot as permanent.\9\ The
extension of the NYSE SLP Pilot until August 1, 2011 runs parallel with
the extension of the NMM pilot: August 1, 2011, or until the Commission
approves the NMM Pilot as permanent.
---------------------------------------------------------------------------

    \8\ See Securities Exchange Act Release Nos. 58877 (October 29,
2008), 73 FR 65904 (November 5, 2008) (SR-NYSE-2008-108) (adopting
SLP pilot program); 59869 (May 6, 2009), 74 FR 22796 (May 14, 2009)
(SR-NYSE-2009-46) (extending SLP pilot program until October 1,
2009); 60756 (October 1, 2009), 74 FR 51628 (October 7, 2009) (SR-
NYSE-2009-100) (extending SLP pilot program until November 30,
2009); 61075 (November 30, 2009), 74 FR 64112 (December 7, 2009)
(SR-NYSE-2009-119) (extending SLP pilot program until March 30,
2010); 61840 (April 5, 2010), 75 FR 18563 (April 12, 2010) (SR-NYSE-
2010-28) (extending the SLP Pilot until September 30, 2010); and
62813 (September 1, 2010), 75 FR 54686 (September 8, 2010) (SR-NYSE-
2010-62) (extending the SLP Pilot until January 31, 2011).
    \9\ See SR-NYSE-2010-86.
---------------------------------------------------------------------------

Proposal To Extend the Operation of the NYSE Amex Equities SLP Pilot
    NYSE Amex Equities established the SLP Pilot to provide incentives
for quoting, to enhance competition among the existing group of
liquidity providers, including the DMMs, and add new competitive market
participants. NYSE Amex Equities Rule 107B is based on NYSE Rule 107B.
NYSE Amex Rule 107B was filed with the Commission on December 30, 2009,
as a ``me too'' filing for immediate effectiveness as a pilot
program.\10\ The NYSE Amex Equities SLP Pilot is scheduled to end
operation on January 31, 2011 or such earlier time as the Commission
may determine to make the rules permanent.
---------------------------------------------------------------------------

    \10\ See Securities Exchange Act Release No. 61308 (January 7,
2010), 75 FR 2573 (January 15, 2010) (SR-NYSEAmex-2009-98).
---------------------------------------------------------------------------

    The Exchange believes that the SLP Pilot, in coordination with the
NMM Pilot and the NYSE SLP Pilot, allows the Exchange to provide its
market participants with a trading venue that utilizes an enhanced
market structure to encourage the addition of liquidity, facilitate the
trading of larger orders more efficiently and operates to reward
aggressive liquidity providers. As such, the Exchange believes that the
rules governing the SLP Pilot (NYSE Amex Equities Rule 107B) should be
made permanent.
    Through this filing the Exchange seeks to extend the current
operation of the SLP Pilot until August 1, 2011, in order to allow the
Exchange to formally submit a filing to the Commission to

convert the Pilot rule to a permanent rule. The Exchange is currently
preparing a rule filing seeking permission to make the NYSE Amex
Equities SLP Pilot permanent, but does not expect that filing to be
completed and approved by the Commission before January 31, 2011.\11\
---------------------------------------------------------------------------

    \11\ The NMM Pilot was scheduled to expire on January 31, 2011
as well. On December 17, 2010 the NYSE filed to extend the NMM Pilot
[sic] until August 1, 2011 (See SR-NYSE-2010-85) (extending the
operation of the New Market Model Pilot to August 1, 2011).
---------------------------------------------------------------------------

2. Statutory Basis
    The basis under the Securities Exchange Act of 1934 (the ``Act'')
for this proposed rule change is the requirement under Section 6(b)(5)
that an exchange have rules that are designed to promote just and
equitable principles of trade, to remove impediments to and perfect the
mechanism of a free and open market and a national market system and,
in general, to protect investors and the public interest. The Exchange
believes that the instant filing is consistent with these principles
because the SLP Pilot provides its market participants with a trading
venue that utilizes an enhanced market structure to encourage the
addition of liquidity and operates to reward aggressive liquidity
providers. Moreover, the instant filing requesting an extension of the
SLP Pilot will permit adequate time for: (i) the Exchange to prepare
and submit a filing to make the rules governing the SLP Pilot
permanent; (ii) public notice and comment; and (iii) completion of the
19b-4 approval process.

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were solicited or received with respect to the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Because the foregoing proposed rule change: (1) Does not
significantly affect the protection of investors or the public
interest; (2) does not impose any significant burden on competition;
and (3) by its terms does not become operative for 30 days after the
date of this filing, or such shorter time as the Commission may
designate if consistent with the protection of investors and the public
interest, the proposed rule change has become effective pursuant to
Section 19(b)(3)(A) of the Act \12\ and Rule 19b-4(f)(6)
thereunder.\13\
---------------------------------------------------------------------------

    \12\ 15 U.S.C. 78s(b)(3)(A).
    \13\ 17 CFR 240.19b-4(f)(6). In addition, Rule 19b-4(f)(6)(iii)
requires a self-regulatory organization to provide the Commission
with written notice of its intent to file the proposed rule change,
along with a brief description and text of the proposed rule change,
at least five business days prior to the date of filing of the
proposed rule change, or such shorter time as designated by the
Commission. The Exchange has fulfilled this requirement.
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an e-mail to<EMAIL_ADDRESS>Please include
File Number SR-NYSEAmex-2010-123 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-NYSEAmex-2010-123. This
file number should be included on the subject line if e-mail is used.
To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments,
all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for website
viewing and printing in the Commission's Public Reference Room, 100 F
Street, NE., Washington, DC 20549, on official business days between
the hours of 10 a.m. and 3 p.m. Copies of the filing also will be
available for inspection and copying at the principal office of the
Exchange.\14\ All comments received will be posted without change; the
Commission does not edit personal identifying information from
submissions. You should submit only information that you wish to make
available publicly. All submissions should refer to File Number SR-
NYSEAmex-2010-123 and should be submitted on or before January 26,
2011.
---------------------------------------------------------------------------

    \14\ The text of the proposed rule change is available on the
Commission's Web site at http://www.sec.gov.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\15\
---------------------------------------------------------------------------

    \15\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Florence E. Harmon,
Deputy Secretary.
[FR Doc. 2010-33255 Filed 1-4-11; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 83, Number 158 (Wednesday, August 15, 2018)]
[Rules and Regulations]
[Page 40454]
[FR Doc No: 2018-17522]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

33 CFR Part 117

[Docket No. USCG-2018-0782]

Drawbridge Operation Regulation; Sacramento River, Sacramento, CA

AGENCY: Coast Guard, DHS.

ACTION: Notice of deviation from drawbridge regulation.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard has issued a temporary deviation from the
operating schedule that governs the Tower Drawbridge across the
Sacramento River, mile 59.0, at Sacramento, CA. The deviation is
necessary to allow commercial filming. This deviation allows the bridge
to remain in the closed-to-navigation position.

DATES: This deviation is effective from 7 a.m. through 9 p.m. on August
25, 2018.

ADDRESSES: The docket for this deviation, USCG-2018-0782, is available
at http://www.regulations.gov. Type the docket number in the ``SEARCH''
box and click ``SEARCH.'' Click on Open Docket Folder on the line
associated with this deviation.

FOR FURTHER INFORMATION CONTACT: If you have questions on this
temporary deviation, call or email Carl T. Hausner, Chief, Bridge
Section, Eleventh Coast Guard District; telephone<PHONE_NUMBER>, email
[email protected].

SUPPLEMENTARY INFORMATION: The California Department of Transportation
has requested a temporary change to the operation of the Tower
Drawbridge, mile 59.0, over Sacramento River, at Sacramento, CA. The
drawbridge navigation span provides a vertical clearance of 30 feet
above Mean High Water in the closed-to-navigation position. The draw
operates as required by 33 CFR 117.189(a). Navigation on the waterway
is commercial and recreational.
    The drawspan will be secured in the closed-to-navigation position
from 7 a.m. to 9 p.m. on August 25, 2018, to allow filming and a
photoshoot for commercial advertisement. This temporary deviation has
been coordinated with the waterway users. No objections to the proposed
temporary deviation were raised. Vessels able to pass through the
bridge in the closed position may do so at anytime. The bridge will be
able to open for emergencies and there is no immediate alternate route
for vessels to pass. The Coast Guard will also inform the users of the
waterway through our Local and Broadcast Notices to Mariners of the
change in operating schedule for the bridge so that vessel operators
can arrange their transits to minimize any impact caused by the
temporary deviation.
    In accordance with 33 CFR 117.35(e), the drawbridge must return to
its regular operating schedule immediately at the end of the effective
period of this temporary deviation. This deviation from the operating
regulations is authorized under 33 CFR 117.35.

    Dated: August 9, 2018.
Carl T. Hausner,
District Bridge Chief, Eleventh Coast Guard District.
[FR Doc. 2018-17522 Filed 8-14-18; 8:45 am]
 BILLING CODE 9110-04-P


[Federal Register Volume 85, Number 229 (Friday, November 27, 2020)]
[Notices]
[Pages 76072-76073]
[FR Doc No: 2020-26204]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2018-0436; FRL-10017-15]

Di-isononyl Phthalate (DINP); Draft Scope of the Risk Evaluation
To Be Conducted Under the Toxic Substances Control Act (TSCA); Notice
of Availability and Request for Comments

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) is announcing the
availability of and soliciting public comment on the draft scope
document for the risk evaluation to be conducted for di-isononyl
phthalate (DINP) (1,2-benzene-dicarboxylic acid, 1,2-diisononyl ester,
and 1,2-benzenedicarboxylic acid, di-C8-10-branched alkyl esters, C9-
rich; Chemical Abstracts Service Registry Number (CASRN) 28553-12-0 and
CASRN 68515-48-0) a category of chemical substances for which EPA
received a manufacturer request for risk evaluation. The draft scope
document for this category of chemical substances includes the
conditions of use, hazards, exposures, and the potentially exposed or
susceptible subpopulations EPA plans to consider in conducting the risk
evaluation for this category of chemical substances. EPA is also asking
the public to provide additional data or information that could be
useful to the Agency in finalizing the scope of the risk evaluations;
comments may be submitted to this docket.

DATES: Comments must be received on or before January 11, 2021.

ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPPT-2018-0436, through the Federal eRulemaking
Portal at http://www.regulations.gov. Follow the online instructions
for submitting comments. Do not submit electronically any information
you consider to be Confidential Business Information (CBI) or other
information whose disclosure is restricted by statute. To make special
arrangements for hand delivery or delivery of boxed information, please
follow the instructions at http://www.epa.gov/dockets/contacts.html.
    Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Reading Room is closed to visitors with
limited exceptions. The staff continues to provide remote customer
service via email, phone, and webform. For the latest status
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: For technical information contact:
Collin Beachum, Existing Chemical Risk Assessment Division (Mailcode
E205-02), Office of Pollution Prevention and Toxics, Environmental
Protection Agency, 109 T.W. Alexander Drive,

RTP, NC 27711; telephone number:<PHONE_NUMBER>; email address:
<EMAIL_ADDRESS>    For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    This action is directed to the public in general and may be of
interest to entities that manufacture (including import) a chemical
substance regulated under TSCA (e.g., entities identified under North
American Industrial Classification System (NAICS) codes 325 and
324110). The action may also be of interest to chemical processors,
distributors in commerce, and users; non-governmental organizations in
the environmental and public health sectors; state and local government
agencies; and members of the public. Since other entities may also be
interested, the Agency has not attempted to describe all the specific
entities and corresponding NAICS codes for entities that may be
interested in or affected by this action.

B. What is the Agency's authority for taking this action?

    The draft scope document is issued pursuant to TSCA section 6(b)
and EPA's implementing regulations at 40 CFR 702.41(c)(7).

C. What action is the Agency taking?

    EPA is publishing the draft scope of the risk evaluation for DINP
under TSCA. Through the risk evaluation process, EPA will determine
whether the category of chemical substances presents an unreasonable
risk of injury to health or the environment under the conditions of
use, as determined by the Administrator, in accordance with TSCA
section 6(b)(4).

II. Background

    TSCA allows chemical manufacturers to request an EPA-conducted risk
evaluation of a chemical under 40 CFR 702.37. On May 24, 2019, EPA
received a manufacturer request for a risk evaluation of DINP (Ref. 1).
On December 20, 2019, the Agency granted the request, and subsequently
initiated the scoping process for the risk evaluation for this category
of chemical substances. The purpose of a risk evaluation is to
determine whether a chemical substance, or group of chemical
substances, presents an unreasonable risk to health or the environment,
under the conditions of use, including an unreasonable risk to a
relevant potentially exposed or susceptible subpopulation (15 U.S.C.
2605(b)(4)(A)). As part of this process, EPA must evaluate both hazards
and exposures for the conditions of use; describe whether aggregate or
sentinel exposures were considered and the basis for consideration; not
consider costs or other nonrisk factors; take into account where
relevant, likely duration, intensity, frequency, and number of
exposures; and describe the weight of the scientific evidence for
hazards and exposures (15 U.S.C. 2605(b)(4)(F)). This process will
culminate in a determination of whether or not the category of chemical
substances presents an unreasonable risk of injury to health or the
environment under the conditions of use (15 U.S.C. 2605(b)(4)(A); 40
CFR 702.47).

III. Draft Scope of the Risk Evaluation for Di-isononyl phthalate
(DINP)

    The category of chemical substances for which EPA is publishing the
draft scope of the risk evaluation includes the following chemical
substances: 1,2-benzene-dicarboxylic acid, 1,2-diisononyl ester (CASRN
28553-12-0), and 1,2-benzenedicarboxylic acid, di-C8-10-branched alkyl
esters, C9-rich; (CASRN 68515-48-0). The draft scope of the risk
evaluation for this category of chemical substances includes the
conditions of use, hazards, exposures, and the potentially exposed or
susceptible subpopulations EPA plans to consider in the risk evaluation
(15 U.S.C. 2605(b)(4)(D)). Development of the scope is the first step
of a risk evaluation. The draft scope of the risk evaluation will
include the following components (40 CFR 702.41(c)):
     The conditions of use, as determined by the Administrator,
that EPA plans to consider in the risk evaluation.
     The potentially exposed populations that EPA plans to
evaluate; the ecological receptors that EPA plans to evaluate; and the
hazards to health and the environment that EPA plans to evaluate.
     A description of the reasonably available information and
the science approaches that the Agency plans to use.
     A conceptual model that will describe the actual or
predicted relationships between the chemical substance, the conditions
of use within the scope of the evaluation and the receptors, either
human or environmental, with consideration of the life cycle of the
chemical substance--from manufacturing, processing, distribution in
commerce, use, to release or disposal--and identification of human and
ecological health hazards EPA plans to evaluate for the exposure
scenarios EPA plans to evaluate.
     An analysis plan, which will identify the approaches and
methods EPA plans to use to assess exposure, hazards, and risk,
including associated uncertainty and variability, as well as a strategy
for using reasonably available information and best available science
approaches.
     A plan for peer review.
    EPA encourages commenters to provide information they believe might
be missing or may further inform the risk evaluation. EPA will publish
a notice in the Federal Register announcing the availability of the
final scope within three months of publishing the draft scope.

IV. References

    The following is a listing of the documents that are specifically
referenced in this Federal Register notice. The docket for this action
includes these documents and other information considered by EPA,
including documents that are referenced within the documents that are
included in the docket. For assistance in locating these referenced
documents, please consult the technical person listed under FOR FURTHER
INFORMATION CONTACT.
    1. EPA. Di-isononyl Phthalate (DINP) (1,2-Benzene- dicarboxylic
acid, 1,2- diisononyl ester); Manufacturer Request for Risk Evaluation
Under the Toxic Substances Control Act (TSCA); Notice of Availability
and Request for Comments. Federal Register. (84 FR 42912, August 19,
2019) (FRL-9998-25).

(Authority: 15 U.S.C. 2601 et seq.)

Andrew Wheeler,
Administrator.
[FR Doc. 2020-26204 Filed 11-25-20; 8:45 am]
BILLING CODE 6560-50-P